KRAS and malignant colon neoplasm: In CRC, oncogenic KRAS is required to maintain changes in cytoskeletal organization, adhesion, and motility of colon cancer cells [62]; however, differential effects of oncogenic KRAS and N-RAS have been reported on proliferation, differentiation and tumor progression in the colon [63].